Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Babich

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Clinics in Liver Disease|November 23, 2019
Drug-Induced Liver Injury Resources and Reporting for the ClinicianMarisa Isaacson, Michael Babich
Oncotargets and Therapy|December 7, 2019
Labyrinthin, The Tumor Marker Recognized By MCA 44-3A6: A Case For Pan-Tumor Markers As Targets To Treat CancerJames A Radosevich, Michael Babich
Advances in Virology|August 2, 2012
Hepatitis C variability, patterns of resistance, and impact on therapyCristina Simona Strahotin, Michael Babich
Clinics in Liver Disease|November 28, 2024
The Role of Palliative Care in the Management of Patients with Hepatocellular CarcinomaNabeeha Mohy-Ud-Din, Michael Babich
Case Reports in Gastroenterology|July 13, 2016
Idiopathic Adulthood Ductopenia: 'It Is Out There'Mohammad Bilal, Ali Kazemi, Michael Babich
Drugs of Today (Barcelona, Spain : 1998)|May 14, 2009
Fundamentals of antibody-related therapy and diagnosticsHuguette Albrecht, James A Radosevich, Michael Babich
BMJ Case Reports|January 29, 2015
Intense pruritus in Epstein-Barr virus (EBV) hepatitis treated with naloxone dripSatyanisth Agrawal, Ryan O'Connor, Elie Aoun, et al.
Case Reports in Hepatology|August 5, 2015
Linoleic Acid Induced Acute Hepatitis: A Case Report and Review of the LiteratureMohammad Bilal, Yogesh Patel, Micheal Burkitt, et al.
Digestive Diseases and Sciences|February 24, 2021
Gastroenterology Fellowship Applicants' Perspectives on GI Program PreferencesUsman Tariq, Shifa Umar, Suzanne Morrissey, et al.
Heliyon|March 7, 2022
Labyrinthin: A distinct pan-adenocarcinoma diagnostic and immunotherapeutic tumor specific antigenMichael Babich, Ankit Sharma, Tianhong Li, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Clinics in Liver Disease|November 23, 2019
Drug-Induced Liver Injury Resources and Reporting for the ClinicianMarisa Isaacson, Michael Babich
Oncotargets and Therapy|December 7, 2019
Labyrinthin, The Tumor Marker Recognized By MCA 44-3A6: A Case For Pan-Tumor Markers As Targets To Treat CancerJames A Radosevich, Michael Babich
Advances in Virology|August 2, 2012
Hepatitis C variability, patterns of resistance, and impact on therapyCristina Simona Strahotin, Michael Babich
Clinics in Liver Disease|November 28, 2024
The Role of Palliative Care in the Management of Patients with Hepatocellular CarcinomaNabeeha Mohy-Ud-Din, Michael Babich
Case Reports in Gastroenterology|July 13, 2016
Idiopathic Adulthood Ductopenia: 'It Is Out There'Mohammad Bilal, Ali Kazemi, Michael Babich
Drugs of Today (Barcelona, Spain : 1998)|May 14, 2009
Fundamentals of antibody-related therapy and diagnosticsHuguette Albrecht, James A Radosevich, Michael Babich
BMJ Case Reports|January 29, 2015
Intense pruritus in Epstein-Barr virus (EBV) hepatitis treated with naloxone dripSatyanisth Agrawal, Ryan O'Connor, Elie Aoun, et al.
Case Reports in Hepatology|August 5, 2015
Linoleic Acid Induced Acute Hepatitis: A Case Report and Review of the LiteratureMohammad Bilal, Yogesh Patel, Micheal Burkitt, et al.
Digestive Diseases and Sciences|February 24, 2021
Gastroenterology Fellowship Applicants' Perspectives on GI Program PreferencesUsman Tariq, Shifa Umar, Suzanne Morrissey, et al.
Heliyon|March 7, 2022
Labyrinthin: A distinct pan-adenocarcinoma diagnostic and immunotherapeutic tumor specific antigenMichael Babich, Ankit Sharma, Tianhong Li, et al.
Pageof 2